Powder & Bulk Solids is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

MilliporeSigma Invests $20 Million in New Switzerland Lab

Image courtesy of MilliporeSigma Laboratory_Millipore.jpg
MilliporeSigma plans to build a new $20 million laboratory facility in Buchs, Switzerland to support its rapidly growing reference materials business.

MilliporeSigma plans to build a new, $20 million laboratory facility in Buchs, Switzerland to support its rapidly growing reference materials business. MilliporeSigma anticipates that about two dozen jobs will be created.

"Researchers in testing labs around the world use MilliporeSigma’s reference materials every day to help generate accurate, reliable analytical results in pharmaceutical, environmental, and food and beverage analysis,” said Jean-Charles Wirth, head of applied solutions at MilliporeSigma. “This new laboratory will allow us to continue to drive innovation in diagnostics and testing and expand our research and development of analytical standards.”

Completion of the three-story, 12,000-sq-ft Buchs building is scheduled for December 2021 and the move is planned for early 2022. The modern, flexible workplace design will include laboratory and office space, and is aimed at fostering a collaborative environment for its 40 employees, some of whom will move from the existing, heavily utilized building. The new facility will offer a more efficient way of working for current and future employees in research and development, analytical production, and quality control. The laboratory area can be adapted to new requirements in the future, including increased site capacity.

Founded in 1950, the Buchs location is one of MilliporeSigma’s most important research and development centers. Today, about 450 people are employed at the site. Here, certified reference materials, analytical standards and reagents, building blocks, and bioanalytical reagents are produced for the company’s global academia, industrial research, and quality control laboratory customers. The site also develops and manufactures raw materials for pharmaceutical manufacturing under Good Manufacturing Practices, as well as active pharmaceutical ingredients. The location serves as a main down-filling hub for MilliporeSigma.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.